ATLANTA, GA USA (UroToday) - In his podium presentation, Victor Nitti, MD, NYU Langone Medical Center, reported on the urodynamic safety of mirabegron based on a phase II bladder outlet obstruction (BOO) clinical trial (Abstract 1869).
To read more, a FREE Urotoday registration is required. Click here to register or login above.website design firm : Web-JIVE LLC